Pathstone Family Office, LLC Intellia Therapeutics, Inc. Transaction History

Pathstone Family Office, LLC

  • $15.6 Billion
  • Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 6,438 shares of NTLA stock, worth $146,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,438
Previous 5,352 20.29%
Holding current value
$146,528
Previous $218,000 6.88%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$31.62 - $45.78 $34,339 - $49,717
1,086 Added 20.29%
6,438 $203,000
Q2 2023

Jan 12, 2024
SELL
$34.58 - $46.03 $37,553 - $49,988
-1,086 Reduced 16.87%
5,352 $218,000
Q2 2023

Aug 14, 2023
SELL
$34.58 - $46.03 $6,258 - $8,331
-181 Reduced 3.27%
5,352 $218,000
Q1 2023

May 15, 2023
SELL
$33.3 - $44.82 $9,357 - $12,594
-281 Reduced 4.83%
5,533 $206,000
Q4 2022

Oct 23, 2023
SELL
$33.21 - $62.69 $1,394 - $2,632
-42 Reduced 0.72%
5,814 $202,000
Q4 2022

Feb 13, 2023
SELL
$33.21 - $62.69 $1,394 - $2,632
-42 Reduced 0.72%
5,814 $202,000
Q3 2022

Oct 23, 2023
SELL
$53.92 - $71.7 $5,607 - $7,456
-104 Reduced 1.74%
5,856 $327,000
Q3 2022

Nov 14, 2022
SELL
$53.92 - $71.7 $5,607 - $7,456
-104 Reduced 1.74%
5,856 $327,000
Q2 2022

Oct 23, 2023
BUY
$38.49 - $76.21 $23,401 - $46,335
608 Added 11.36%
5,960 $308,000
Q2 2022

Aug 15, 2022
BUY
$38.49 - $76.21 $85,024 - $168,347
2,209 Added 58.89%
5,960 $309,000
Q1 2022

May 16, 2022
SELL
$58.27 - $118.99 $1,048 - $2,141
-18 Reduced 0.48%
3,751 $273,000
Q4 2021

Feb 14, 2022
SELL
$100.76 - $138.36 $3,123 - $4,289
-31 Reduced 0.82%
3,769 $445,000
Q3 2021

Nov 16, 2021
BUY
$132.37 - $176.78 $2,250 - $3,005
17 Added 0.45%
3,800 $509,000
Q2 2021

Aug 31, 2021
SELL
$60.88 - $161.91 $80,483 - $214,045
-1,322 Reduced 25.9%
3,783 $613,000
Q1 2021

May 14, 2021
BUY
$46.59 - $83.68 $153,327 - $275,390
3,291 Added 181.42%
5,105 $410,000
Q2 2020

Aug 14, 2020
SELL
$11.14 - $22.87 $20,207 - $41,486
-1,814 Closed
0 $0
Q3 2018

Nov 09, 2018
BUY
$25.78 - $32.6 $46,764 - $59,136
1,814 New
1,814 $52,000
Q2 2018

Aug 10, 2018
SELL
$20.02 - $30.79 $36,316 - $55,853
-1,814 Closed
0 $0
Q4 2017

Feb 12, 2018
BUY
$17.39 - $31.12 $31,545 - $56,451
1,814 New
1,814 $35,000
Q3 2017

Nov 14, 2017
SELL
$15.16 - $25.75 $27,500 - $46,710
-1,814 Closed
0 $0
Q2 2017

Aug 16, 2017
BUY
N/A
1,814
1,814 $29,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
89.3M
Call Options Held
686K
Put Options Held
599K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.73B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email